PROFILE: Bangladesh Market On Uptrend Amid Hep C Buildup
This article was originally published in PharmAsia News
Executive Summary
Half a dozen corporate players, community-based diagnosis and patient support efforts, and an inflow of treatment seekers from abroad keen to access cut-price drugs in the country – this probably summarizes the current state of play in Bangladesh's market for sofosbuvir.